Summary & Overview
CPT 31660: Bronchoscopic Radiofrequency Airway Ablation
CPT code 31660 represents bronchoscopic radiofrequency ablation of airway smooth muscle performed under bronchoscopic visualization, typically on a single pulmonary lobe. This procedure targets airway hyperresponsiveness in patients with severe, treatment-refractory asthma and has national relevance as an advanced, device-based therapeutic option in pulmonary care. Payers reviewed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find an overview of the clinical purpose and procedural setting for CPT code 31660, plus national-level coverage context and typical payer considerations. The publication summarizes common billing modifiers, the usual site-of-service settings (hospital outpatient departments and ambulatory surgical centers), and links to clinical context for severe asthma management. It also outlines what to expect in claims processing and documentation needs tied to bronchoscopic therapeutic procedures. Where specific payer policy details or benchmarks are not available in the input, the report notes that data are not provided and focuses on observable clinical and coding characteristics for national audiences.
Billing Code Overview
CPT code 31660 describes a bronchoscopic procedure in which a provider introduces a radiofrequency catheter into the bronchus to deliver radiofrequency energy to airway smooth muscle. The intent of the procedure is to treat airway hyperresponsiveness and reduce bronchoconstriction in patients with severe, treatment-refractory asthma.
Service type: Therapeutic bronchoscopic radiofrequency ablation of airway smooth muscle
Typical site of service: Hospital outpatient department or ambulatory surgical center under bronchoscopic visualization
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with severe, persistent, treatment-refractory asthma presents for bronchoscopic radiofrequency thermal therapy targeting airway smooth muscle in a single pulmonary lobe. Prior to the procedure the patient completes preoperative evaluation including pulmonary function testing (spirometry with bronchodilator responsiveness), recent chest imaging as indicated, assessment of inhaled and systemic corticosteroid use, and optimization of comorbid conditions. On the day of service the patient is admitted to an ambulatory surgery center or hospital operating room with monitored anesthesia care or general endotracheal anesthesia. Under bronchoscopic visualization, the interventional pulmonologist introduces a specialized radiofrequency catheter into the target bronchus and delivers controlled radiofrequency energy to reduce airway smooth muscle mass. Post-procedure monitoring occurs in a recovery area with assessment of respiratory status, oxygenation, and readiness for discharge or inpatient transfer. Documentation includes indication, informed consent, details of bronchoscopic visualization, lobe treated, number of activations, energy settings, anesthesia type, complications if any, and post-procedure instructions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normally performed service | Use when this procedure is the usual service performed by the provider during the encounter. |